检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Inotuzumab Ozogamicin (InO) Combined with UKALL-R3 Modified Chemotherapy in Pediatric Patients with B-Cell Precursor CD22+ Acute Lymphoblastic Leukemia (BCP-ALL) - Results from the ITCC-059 Phase 1B Trial

Edoardo Pennesi,Erica Brivio,Anneke C.J. Ammerlaan,Yilin Jiang, Vincent H.J. van der Velden,Berna Beverloo,Barbara Sleight,Susana Rives,Cristina Díaz de Heredia Rubio,Francisco J. Bautista Sirvent, Alba Rubio-San-Simón,Fanny Rialland,Carmelo Rizzari,Bella Bielorai,Arnaud Petit,Bénédicte Bruno,Ingrid Øra,Anna Nilsson,Gernot Engstler,Claudia Rossig

PEDIATRIC BLOOD & CANCER（2022）

引用 1|浏览41
暂无评分
关键词
inotuzumab ozogamicin,acute lymphoblastic leukemia,chemotherapy,pediatric patients,b-cell,bcp-all
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要